Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease

Strachan, David Peter, Carrington, David, Mendall, Michael, Butland, Barbara Karen, Yarnell, John William Gordon and Elwood, Peter Creighton 2000. Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease. American Journal of Respiratory and Critical Care Medicine 161 (2) , pp. 493-497. 10.1164/ajrccm.161.2.9904055

Full text not available from this repository.

Abstract

Associations have been reported between Chlamydia pneumoniae seropositivity and both acute and chronic obstructive airway diseases. Plasma specimens collected between 1979 and 1983 from 1,773 men 45 to 59 yr of age in Caerphilly, South Wales, were tested for IgG and IgA antibodies to C. pneumoniae (TW183) by microimmunofluorescence. Subsequent mortality and medication for obstructive airway disease were ascertained at 5-yr follow-up examinations. Spirometry was performed at the first and second examinations and analyzed both cross-sectionally and longitudinally; 642 men (36%) had IgG antibodies at a titer of 1:16 or above, of whom 362 also had detectable IgA antibodies. No statistically significant associations were found between either IgG titer or IgA titer and any of the outcome measures: inhaler therapy at entry; commencement of inhalers during follow-up; death from respiratory causes; baseline FEV1, FVC, and FEV1/FVC ratio; and decline in FEV1 (p > 0.1 throughout). Men with high IgG titers ( ⩾ 1:64) had a slower rate of decline of FEV1 than did seronegative subjects (adjusted mean difference in 5-yr change in FEV1: + 22 ml, 95% confidence interval: − 31 ml to + 76 ml). Men with high IgA titers ( ⩾ 1:16) had a slightly faster rate of decline ( − 12 ml, − 96 ml to + 71 ml). This first prospective assessment suggests that chronic C. pneumoniae infection is not a major risk factor for progressive airflow obstruction. Strachan DP, Carrington D, Mendall M, Butland BK, Yarnell JWG, Elwood P. Chlamydia pneumoniae serology, lung function decline and treatment for respiratory disease.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	American Thoracic Society
ISSN:	1073-449X
Last Modified:	10 Jun 2023 01:19
URI:	https://orca.cardiff.ac.uk/id/eprint/64640

Citation Data

Cited 28 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item